Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Revenue

Xilio Therapeutics had revenue of $19.07M in the quarter ending September 30, 2025, with 742.51% growth. This brings the company's revenue in the last twelve months to $31.80M, up 588.40% year-over-year. In the year 2024, Xilio Therapeutics had annual revenue of $6.34M.

• Revenue (ttm): $31.80M
• Revenue Growth: +588.40%
• P/S Ratio: 0.87
• Revenue / Employee: $496,938
• Employees: 64
• Market Cap: 36.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.34M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-